ARCHIVES

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

This article is from The Cancer Letter archive.

Vol. 04 No. 33 | August 18, 1978

Download PDF Visit The Full Archive

Related Articles

DCT Board To Consider RFA for Clinical R01 Grants At Next Meetings

January 21, 1994

Hypothyroidism Associated With Reduced Breast Cancer

April 25, 2003

NCAB Approves CCP, Agrees To Compromise On Including Control

May 21, 1982

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

Mack, to Retire, Calls Budget Proposal an “Act of Retreat”

March 19, 1999

New NCI Director Proposes $9 Million Community Cancer Centers Program.

September 8, 2006